Table 2.

Peak saccade velocity, percentage of response in SHIMPs, and HIMP VOR gain in the lesioned and intact side of acute UVL patients.

	Lesioned side				Intact side
	Stage (weeks)	Peak saccade velocity (°/s)	% of response in SHIMP	HVOR gain HIMP	Peak saccade velocity (°/s)	% of response in SHIMP	HVOR gainHIMP
Patient 1	1	89	57	0.37	391	100	0.84
Patient 2	1	38	33	0.35	519	100	0.79
Patient 3	1	81	48	0.41	438	100	0.80
Patient 4	1	74	57	0.41	412	100	0.96
Patient 5	1	15	15	0.33	251	100	0.74
Patient 6	1	58	10	0.44	324	100	0.79
Patient 7	1	88	30	0.31	311	100	0.73
Patient 8	1	111	55	0.25	370	100	0.91
Patient 9	1	0	0	0.27	242	100	1.11
Patient 10	1	121	62	0.46	406	100	0.98
Patient 11	1	56	67	0.37	495	100	0.85
Patient 12	1	138	58	0.38	335	100	0.98
Patient 13	1	43	20	0.24	335	100	0.82
Patient 14	1	0	0	0.29	341	100	0.99
Patient 15	3	0	0	0.28	342	100	0.83
Patient 16	3	149	46	0.52	376	100	0.74
Patient 17	3	103	55	0.26	210	100	1.02
Patient 18	3	63	25	0.18	268	100	0.84
Patient 19	3	44	20	0.21	335	100	0.73
Patient 20	6	0	0	0.23	285	100	0.78
Patient 21	6	163	75	0.57	342	100	0.78
Patient 22	6	0	0	0.32	437	100	0.76
Patient 23	6	47	50	0.32	380	100	0.76
Mean ± SD		64 ± 50*	34 ± 25*	0.34 ± 0.10*	354 ± 77	100 ± 0	0.85 ± 0.11

Notice the significant decrease of mean peak saccade velocity and HIMP HVOR gain on their lesioned sides compared with those in their intact sides. In addition, the percentage of saccade response is decreased on head turns toward the lesioned side (34%) compared with the one obtained in head turns on the intact side (100%).

*indicates significantly difference in t-test, p < 0.05.